A Distinct Replication Fork Protection Pathway Connects Fanconi Anemia Tumor Suppressors to RAD51-BRCA1/2

Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints

Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986

Double-Strand Break Repair-Independent Role for BRCA2 in Blocking Stalled Replication Fork Degradation by MRE11

Schlacher, K., Christ, N., Siaud, N., Egashira, A., Wu, H., & Jasin, M. (2011) · Cell · doi:10.1016/j.cell.2011.03.041 · Cited by 1,292

Brca1 Controls Homology-Directed DNA Repair

Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245

Interaction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway

Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M. S., Timmers, C., Hejna, J., Grompe, M., & D'Andrea, A. D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00173-3 · Cited by 1,198

Nucleotide deficiency promotes genomic instability in early stages of cancer development

Bester, A. C., Roniger, M., Oren, Y. S., Im, M. M., Sarni, D., Chaoat, M., Bensimon, A., Zamir, G., Shewach, D. S., & Kerem, B. (2011) · Cell · doi:10.1016/j.cell.2011.03.044 · Cited by 858

Advanced pancreatic carcinoma: current treatment and future challenges

Stathis, A., & Moore, M. J. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.236 · Cited by 791

Stable Interaction between the Products of the BRCA1 and BRCA2 Tumor Suppressor Genes in Mitotic and Meiotic Cells

Chen, J., Silver, D. P., Walpita, D., Cantor, S. B., Gazdar, A. F., Tomlinson, G. E., Couch, F. J., Weber, B. L., Ashley, T., Livingston, D. M., et al. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80276-2 · Cited by 635

How the Fanconi Anemia Pathway Guards the Genome

Moldovan, G., & D’Andrea, A. D. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102108-134222 · Cited by 601

Rad51 protects nascent DNA from Mre11-dependent degradation and promotes continuous DNA synthesis

Hashimoto, Y., Chaudhuri, A. R., Lopes, M., & Costanzo, V. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1927 · Cited by 537

The Fanconi Anemia Pathway Promotes Replication-Dependent DNA Interstrand Cross-Link Repair

Knipscheer, P., Räschle, M., Smogorzewska, A., Enoiu, M., Ho, T. V., Schärer, O. D., Elledge, S. J., & Walter, J. C. (2009) · Science · doi:10.1126/science.1182372 · Cited by 525

Causes and consequences of replication stress

Zeman, M. K., & Cimprich, K. A. (2014) · Nature Cell Biology · doi:10.1038/ncb2897 · Cited by 2,079

The multifaceted roles of PARP1 in DNA repair and chromatin remodelling

Ray Chaudhuri, A., & Nussenzweig, A. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.53 · Cited by 1,786

DNA double-strand break repair-pathway choice in somatic mammalian cells

Scully, R., Panday, A., Elango, R., & Willis, N. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0152-0 · Cited by 1,542

Replication stress and cancer

Gaillard, H., García‐Muse, T., & Aguilera, A. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3916 · Cited by 1,134

Replication fork stability confers chemoresistance in BRCA-deficient cells

Chaudhuri, A. R., Callén, E., Ding, X., Gogola, E., Duarte, A. A., Lee, J., Wong, N., Lafarga, V., Calvo, J. A., Panzarino, N. J., et al. (2016) · Nature · doi:10.1038/nature18325 · Cited by 949

Homologous Recombination and Human Health: The Roles of BRCA1, BRCA2, and Associated Proteins

Prakash, R., Zhang, Y., Feng, W., & Jasin, M. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016600 · Cited by 869

Targeting DNA damage response pathways in cancer

Groelly, F. J., Fawkes, M., Dagg, R. A., Blackford, A. N., & Tarsounas, M. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00535-5 · Cited by 890

R loops: new modulators of genome dynamics and function

Santos-Pereira, J. M., & Aguilera, A. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3961 · Cited by 787

A decade of clinical development of PARP inhibitors in perspective

Mateo, J., Lord, C. J., Serra, V., Tutt, A., Balmaña, J., Castroviejo-Bermejo, M., Cruz, C., Oaknin, A., Kaye, S. B., & de Bono, J. S. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz192 · Cited by 743

The Fanconi anaemia pathway: new players and new functions

Ceccaldi, R., Sarangi, P., & D’Andrea, A. D. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.48 · Cited by 727

PARP and PARG inhibitors in cancer treatmentPreprint

Slade, D. (2020) · Genes & Development · doi:10.1101/gad.334516.119 · Cited by 693

Rad51-mediated replication fork reversal is a global response to genotoxic treatments in human cells

Zellweger, R., Dalcher, D., Mutreja, K., Berti, M., Schmid, J. A., Herrador, R., Vindigni, A., & Lopes, M. (2015) · The Journal of Cell Biology · doi:10.1083/jcb.201406099 · Cited by 691

Fanconi anaemia and the repair of Watson and Crick DNA crosslinks

Kottemann, M. C., & Smogorzewska, A. (2013) · Nature · doi:10.1038/nature11863 · Cited by 624

CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours

Xu, H., Antonio, M. D., McKinney, S. E., Mathew, V., Ho, B., O’Neil, N. J., Santos, N. D., Silvester, J., Wei, V., Garcia, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms14432 · Cited by 601

PARP inhibitor resistance: the underlying mechanisms and clinical implications

Li, H., Liu, Z., Wu, N., Chen, Y., Cheng, Q., & Wang, J. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01227-0 · Cited by 578

BRCA2 prevents R-loop accumulation and associates with TREX-2 mRNA export factor PCID2

Bhatia, V., Barroso, S. I., García-Rubio, M. L., Tumini, E., Herrera‐Moyano, E., & Aguilera, A. (2014) · Nature · doi:10.1038/nature13374 · Cited by 527

Understanding and overcoming resistance to PARP inhibitors in cancer therapy

Dias, M. P., Moser, S. C., Ganesan, S., & Jonkers, J. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00532-x · Cited by 544

Loss of 53BP1 Causes PARP Inhibitor Resistance in Brca1 -Mutated Mouse Mammary Tumors

Jaspers, J. E., Kersbergen, A. J., Boon, U., Sol, W., van Deemter, L., Zander, S. A. L., Drost, R., Wientjens, E., Ji, J. J., Aly, A., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0049 · Cited by 532

High speed of fork progression induces DNA replication stress and genomic instability

Maya-Mendoza, A., Moudry, P., Merchut-Maya, J. M., Lee, M., Strauss, R., & Bartek, J. (2018) · Nature · doi:10.1038/s41586-018-0261-5 · Cited by 514

Replication fork reversal in eukaryotes: from dead end to dynamic response

Neelsen, K. J., & Lopes, M. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3935 · Cited by 523

Mechanisms of PARP inhibitor sensitivity and resistance

D’Andrea, A. D. (2018) · DNA repair · doi:10.1016/j.dnarep.2018.08.021 · Cited by 502

PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells

Noordermeer, S. M., & van Attikum, H. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.07.008 · Cited by 472

Hallmarks of DNA replication stress

Saxena, S., & Zou, L. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.05.004 · Cited by 486

Identification of Early Replicating Fragile Sites that Contribute to Genome Instability

Barlow, J. H., Faryabi, R. B., Callén, E., Wong, N., Malhowski, A. J., Chen, H. T., Gutierrez-Cruz, G., Sun, H., McKinnon, P. J., Wright, G. W., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.006 · Cited by 464

Mechanisms of Oncogene-Induced Replication Stress: Jigsaw Falling into Place

Kotsantis, P., Petermann, E., & Boulton, S. J. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1461 · Cited by 416

MRE11 and EXO1 nucleases degrade reversed forks and elicit MUS81-dependent fork rescue in BRCA2-deficient cells

Lemacon, D. S., Jackson, J., Quinet, A., Brickner, J. R., Li, S., Yazinski, S. A., You, Z., Ira, G., Zou, L., Mosammaparast, N., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01180-5 · Cited by 429

DNA repair mechanisms in cancer development and therapy

Torgovnick, A., & Schumacher, B. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00157 · Cited by 427

BRCA1–BARD1 promotes RAD51-mediated homologous DNA pairing

Zhao, W., Steinfeld, J. B., Liang, F., Chen, X., Maranon, D. G., Jian Ma, C., Kwon, Y., Rao, T., Wang, W., Sheng, C., et al. (2017) · Nature · doi:10.1038/nature24060 · Cited by 393

ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cellsPreprint

Yazinski, S. A., Comaills, V., Buisson, R., Genois, M., Nguyen, H. D., Ho, C. K., Kwan, T. T., Morris, R. T., Lauffer, S., Nussenzweig, A., et al. (2017) · Genes & Development · doi:10.1101/gad.290957.116 · Cited by 405

Restoration of Replication Fork Stability in BRCA1- and BRCA2-Deficient Cells by Inactivation of SNF2-Family Fork Remodelers

Taglialatela, A., Álvarez, S., Leuzzi, G., Sannino, V., Ranjha, L., Huang, J., Madubata, C. J., Anand, R., Levy, B., Rabadán, R., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.09.036 · Cited by 407

The MRE11–RAD50–NBS1 Complex Conducts the Orchestration of Damage Signaling and Outcomes to Stress in DNA Replication and Repair

Syed, A., & Tainer, J. A. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-012415 · Cited by 404

Fanconi anaemia and cancer: an intricate relationship

Nalepa, G., & Clapp, D. W. (2018) · Nature reviews. Cancer · doi:10.1038/nrc.2017.116 · Cited by 399

The Fanconi Anemia Pathway in Cancer

Joshi, N., Färkkilä, A., & D’Andrea, A. D. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050422 · Cited by 387

Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models

Kim, H., Xu, H., George, E. M., Hallberg, D. L., Kumar, S., Jagannathan, V., Medvedev, S., Kinose, Y., Devins, K. M., Verma, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17127-2 · Cited by 390

Hereditary breast and ovarian cancer: new genes in confined pathways

Nielsen, F. C., van Overeem Hansen, T., & Sørensen, C. S. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.72 · Cited by 367

Smarcal1-Mediated Fork Reversal Triggers Mre11-Dependent Degradation of Nascent DNA in the Absence of Brca2 and Stable Rad51 Nucleofilaments

Kolinjivadi, A. M., Sannino, V., Antoni, A. D., Zadorozhny, K., Kilkenny, M. L., Técher, H., Baldi, G., Shen, R., Ciccia, A., Pellegrini, L., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.07.001 · Cited by 379

Replication fork reversal triggers fork degradation in BRCA2-defective cells

Mijic, S., Zellweger, R., Chappidi, N., Berti, M., Jacobs, K., Mutreja, K., Ursich, S., Chaudhuri, A. R., Nussenzweig, A., Janščák, P., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01164-5 · Cited by 380

The antitumorigenic roles of BRCA1–BARD1 in DNA repair and replication

Tarsounas, M., & Sung, P. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0218-z · Cited by 389

The Fanconi Anemia Pathway Maintains Genome Stability by Coordinating Replication and Transcription

Schwab, R. A., Nieminuszczy, J., Shah, F., Langton, J., Martínez, D. L., Liang, C., Cohn, M. A., Gibbons, R. J., Deans, A. J., & Niedźwiedź, W. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.09.012 · Cited by 376

Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency

Cong, K., Peng, M., Kousholt, A. N., Lee, W. T. C., Lee, S., Nayak, S. U., Krais, J. J., VanderVere-Carozza, P. S., Pawelczak, K. S., Calvo, J. A., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.06.011 · Cited by 360

RPA and RAD51: fork reversal, fork protection, and genome stability

Bhat, K. P., & Cortez, D. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0075-z · Cited by 363

DNA2 drives processing and restart of reversed replication forks in human cells

Thangavel, S., Berti, M., Levikova, M., Pinto, C., Gomathinayagam, S., Vujanovic, M., Zellweger, R., Moore, H. R., Lee, E. H., Hendrickson, E. A., et al. (2015) · The Journal of Cell Biology · doi:10.1083/jcb.201406100 · Cited by 341

The plasticity of DNA replication forks in response to clinically relevant genotoxic stress

Berti, M., Cortez, D., & Lopes, M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0257-5 · Cited by 343

Quantitative Proteomic Atlas of Ubiquitination and Acetylation in the DNA Damage Response

Elia, A. E. H., Boardman, A. P., Wang, D. C., Huttlin, E. L., Everley, R. A., Dephoure, N., Zhou, C., Koren, I., Gygi, S. P., & Elledge, S. J. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.05.006 · Cited by 341

Main steps in DNA double-strand break repair: an introduction to homologous recombination and related processes

Ranjha, L., Howard, S. M., & Ćejka, P. (2018) · Chromosoma · doi:10.1007/s00412-017-0658-1 · Cited by 360

Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies

Marra, A., Trapani, D., Viale, G., Criscitiello, C., & Curigliano, G. (2020) · npj Breast Cancer · doi:10.1038/s41523-020-00197-2 · Cited by 332

Homology-Directed Repair and the Role of BRCA1, BRCA2, and Related Proteins in Genome Integrity and Cancer

Chen, C.-C., Feng, W., Lim, P. X., Kass, E. M., & Jasin, M. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050502 · Cited by 323

Werner syndrome: Clinical features, pathogenesis and potential therapeutic interventions

Oshima, J., Sidorova, J. M., & Monnat, R. J. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.03.002 · Cited by 322

CDK12 inhibition reverses de novo and acquired PARP inhibitor resistance in BRCA Wild-Type and mutated models of Triple-Negative breast Cancer

Johnson, S. F., Cruz, C., Greifenberg, A. K., Dust, S., Stover, D. G., Chi, D., Primack, B., Cao, S., Bernhardy, A. J., Coulson, R., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.077 · Cited by 291

DNA End Resection: Mechanism and Control

Ćejka, P., & Symington, L. S. (2021) · Annual Review of Genetics · doi:10.1146/annurev-genet-071719-020312 · Cited by 294

Human BRCA1–BARD1 ubiquitin ligase activity counteracts chromatin barriers to DNA resection

Densham, R. M., Garvin, A. J., Stone, H. R., Strachan, J., Baldock, R. A., Daza-Martín, M., Fletcher, A., Blair-Reid, S., Beesley, J. F. J., Johal, B., et al. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3236 · Cited by 297

Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches

Dietlein, F., Thelen, L., & Reinhardt, H. C. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.06.003 · Cited by 290

The impact of replication stress on replication dynamics and DNA damage in vertebrate cells

Técher, H., Koundrioukoff, S., Nicolas, A. G., & Debatisse, M. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.46 · Cited by 287

A Dominant Mutation in Human RAD51 Reveals Its Function in DNA Interstrand Crosslink Repair Independent of Homologous Recombination

Wang, A. T., Kim, T., Wagner, J. E., Conti, B. A., Lach, F. P., Huang, A. L., Molina, H., Sanborn, E. M., Zierhut, H. A., Cornes, B. K., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.009 · Cited by 287

PRIMPOL-Mediated Adaptive Response Suppresses Replication Fork Reversal in BRCA-Deficient Cells

Quinet, A., Tirman, S., Jackson, J., Šviković, S., Lemacon, D. S., Carvajal-Maldonado, D., González‐Acosta, D., Vessoni, A. T., Cybulla, E., Wood, M. D., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.10.008 · Cited by 273

RAD51 Gene Family Structure and Function

Bonilla, B., Hengel, S. R., Grundy, M. K., & Bernstein, K. A. (2020) · Annual Review of Genetics · doi:10.1146/annurev-genet-021920-092410 · Cited by 270

Replication stress: getting back on track

Berti, M., & Vindigni, A. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3163 · Cited by 249

The expanding universe of PARP1-mediated molecular and therapeutic mechanisms

Huang, D., & Kraus, W. L. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.02.021 · Cited by 254

FANCD2 Binds MCM Proteins and Controls Replisome Function upon Activation of S Phase Checkpoint Signaling

Lossaint, G., Larroque, M., Ribeyre, C., Bec, N., Larroque, C., Décaillet, C., Gari, K., & Constantinou, A. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.07.023 · Cited by 258

53BP1: a DSB escortPreprint

Mirman, Z., & de Lange, T. (2020) · Genes & Development · doi:10.1101/gad.333237.119 · Cited by 248

PARP1 and PARP2 stabilise replication forks at base excision repair intermediates through Fbh1-dependent Rad51 regulation

Ronson, G. E., Piberger, A. L., Higgs, M. R., Olsen, A. L., Stewart, G. D., McHugh, P. J., Petermann, E., & Lakin, N. D. (2018) · Nature Communications · doi:10.1038/s41467-018-03159-2 · Cited by 238

Chromosome instability syndromes

Taylor, A. M. R., Rothblum‐Oviatt, C., Ellis, N. A., Hickson, I. D., Meyer, S., Crawford, T. O., Smogorzewska, A., Pietrucha, B. M., Weemaes, C. M. R., & Stewart, G. S. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0113-0 · Cited by 242

R Loops and Links to Human Disease

Richard, P., & Manley, J. L. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.08.031 · Cited by 230

Replication Gaps Underlie BRCA Deficiency and Therapy Response

Panzarino, N. J., Krais, J. J., Peng, M., Mosqueda, M., Nayak, S., Bond, S., Calvo, J. A., Cong, K., Doshi, M. B., Bere, M., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1602 · Cited by 209

Cyclin E1 Deregulation Occurs Early in Secretory Cell Transformation to Promote Formation of Fallopian Tube–Derived High-Grade Serous Ovarian Cancers

Karst, A. M., Jones, P., Vena, N., Ligon, A. H., Liu, J. F., Hirsch, M. S., Etemadmoghadam, D., Bowtell, D. D. L., & Drapkin, R. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2247 · Cited by 214

Interplay between Fanconi anemia and homologous recombination pathways in genome integrity

Michl, J., Zimmer, J., & Tarsounas, M. (2016) · The EMBO Journal · doi:10.15252/embj.201693860 · Cited by 217

DNA repair defects in cancer and therapeutic opportunitiesPreprint

Hopkins, J. L., Lan, L., & Zou, L. (2022) · Genes & Development · doi:10.1101/gad.349431.122 · Cited by 212

FANCD2 Maintains Fork Stability in BRCA1/2-Deficient Tumors and Promotes Alternative End-Joining DNA Repair

Kais, Z., Rondinelli, B., Holmes, A. L., O’Leary, C., Kozono, D., D’Andrea, A. D., & Ceccaldi, R. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.031 · Cited by 208

RADX Promotes Genome Stability and Modulates Chemosensitivity by Regulating RAD51 at Replication Forks

Dungrawala, H., Bhat, K. P., Meur, R. A. L., Chazin, W., Ding, X., Sharan, S. K., Wessel, S. R., Sathe, A. A., Zhao, R., & Cortez, D. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.06.023 · Cited by 203

BOD1L Is Required to Suppress Deleterious Resection of Stressed Replication Forks

Higgs, M. R., Reynolds, J. J., Winczura, A., Blackford, A. N., Borel, V., Miller, E. S., Zlatanou, A., Nieminuszczy, J., Ryan, E. L., Davies, N. J., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.007 · Cited by 194

The role of NF-κB in breast cancer initiation, growth, metastasis, and resistance to chemotherapy

Pavitra, E., Kancharla, J., Gupta, V. K., Prasad, K., Sung, J. Y., Kim, J., Tej, M. B., Choi, R., Lee, J., Han, Y., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114822 · Cited by 197

The cGAS/STING Pathway: A Novel Target for Cancer Therapy

Gan, Y., Li, X., Han, S., Liang, Q., Ma, X., Rong, P., Wang, W., & Li, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.795401 · Cited by 194

Mechanisms for stalled replication fork stabilization: new targets for synthetic lethality strategies in cancer treatments

Liao, H., Ji, F., Helleday, T., & Ying, S. (2018) · EMBO Reports · doi:10.15252/embr.201846263 · Cited by 197

Characterization of the interplay between DNA repair and CRISPR/Cas9-induced DNA lesions at an endogenous locus

Bothmer, A., Phadke, T., Barrera, L. A., Margulies, C. M., Lee, C. S., Buquicchio, F., Moss, S., Abdulkerim, H. S., Selleck, W., Jayaram, H., et al. (2017) · Nature Communications · doi:10.1038/ncomms13905 · Cited by 187

Replication Stress-Induced Genome Instability: The Dark Side of Replication Maintenance by Homologous Recombination

Carr, A. M., & Lambert, S. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.04.023 · Cited by 201

BRCA1 haploinsufficiency for replication stress suppression in primary cells

Pathania, S., Bade, S., Guillou, M. L., Burke, K. A., Reed, R., Bowman-Colin, C., Su, Y., Ting, D. T., Polyák, K., Richardson, A. L., et al. (2014) · Nature Communications · doi:10.1038/ncomms6496 · Cited by 183

RAD51 interconnects between DNA replication, DNA repair and immunity

Bhattacharya, S., Kalayarasan, S., Abdisalaam, S., Su, F., Raj, P., Dozmorov, I. M., Mishra, R., Wakeland, E. K., Ghose, S., Mukherjee, S., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx126 · Cited by 185

REV1-Polζ maintains the viability of homologous recombination-deficient cancer cells through mutagenic repair of PRIMPOL-dependent ssDNA gaps

Taglialatela, A., Leuzzi, G., Sannino, V., Cuella-Martin, R., Huang, J., Wu-Baer, F., Baer, R. J., Costanzo, V., & Ciccia, A. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.016 · Cited by 183

USP1 Is Required for Replication Fork Protection in BRCA1-Deficient Tumors

Lim, K. S., Li, H., Roberts, E. A., Gaudiano, E. F., Clairmont, C. S., Sambel, L. A., Ponnienselvan, K., Liu, J., Yang, C., Kozono, D., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.10.045 · Cited by 174

PARP1-Driven Poly-ADP-Ribosylation Regulates BRCA1 Function in Homologous Recombination–Mediated DNA Repair

Hu, Y., Petit, S. A., Ficarro, S. B., Toomire, K. J., Xie, A., Lim, E., Cao, S. A., Park, E., Eck, M. J., Scully, R., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0891 · Cited by 181

The Tandem Duplicator Phenotype Is a Prevalent Genome-Wide Cancer Configuration Driven by Distinct Gene Mutations

Menghi, F., Barthel, F. P., Yadav, V. K., Tang, M., Ji, B., Tang, Z., Carter, G. W., Ruan, Y., Scully, R., Verhaak, R. G. W., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.06.008 · Cited by 179

Preserving replication fork integrity and competence via the homologous recombination pathway

Saada, A. A., Lambert, S., & Carr, A. M. (2018) · DNA repair · doi:10.1016/j.dnarep.2018.08.017 · Cited by 186

The SWI/SNF chromatin remodeling complex helps resolve R-loop-mediated transcription–replication conflicts

Bayona‐Feliú, A., Barroso, S. I., Muñoz, S., & Aguilera, A. (2021) · Nature Genetics · doi:10.1038/s41588-021-00867-2 · Cited by 177

Genomic instability, inflammatory signaling and response to cancer immunotherapy

Chen, M., Linstra, R., & van Vugt, M. A. T. M. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188661 · Cited by 166

Translocation and deletion breakpoints in cancer genomes are associated with potential non-B DNA-forming sequences

Bacolla, A., Tainer, J. A., Vásquez, K. M., & Cooper, D. N. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw261 · Cited by 164

Defining and Modulating ‘BRCAness’

Byrum, A. K., Vindigni, A., & Mosammaparast, N. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.06.005 · Cited by 164

FANCD2 Facilitates Replication through Common Fragile Sites

Madireddy, A., Kosiyatrakul, S. T., Boisvert, R. A., Herrera‐Moyano, E., García-Rubio, M. L., Gerhardt, J., Vuono, E. A., Owen, N. M., Yan, Z., Olson, S. B., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.09.017 · Cited by 174

Lesion Bypass and the Reactivation of Stalled Replication Forks

Marians, K. J. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-011921 · Cited by 175

The BRCA Tumor Suppressor Network in Chromosome Damage Repair by Homologous Recombination

Zhao, W., Wiese, C., Kwon, Y., Hromas, R., & Sung, P. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-013118-111058 · Cited by 169

Targeting the replication stress response in cancer

Forment, J. V., & O’Connor, M. J. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.03.005 · Cited by 161

ATR-Mediated Phosphorylation of FANCI Regulates Dormant Origin Firing in Response to Replication Stress

Chen, Y.-H., Jones, M. V., Yin, Y., Crist, S. B., Colnaghi, L., Sims, R. J., Rothenberg, E., Jallepalli, P. V., & Huang, T. T. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.02.031 · Cited by 167

Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress

Bayard, Q., Meunier, L., Péneau, C., Renault, V., Shinde, J., Nault, J., Mami, I., Couchy, G., Amaddeo, G., Tubacher, E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07552-9 · Cited by 174

Recent discoveries in the molecular pathogenesis of the inherited bone marrow failure syndrome Fanconi anemia

Mamrak, N. E., Shimamura, A., & Howlett, N. G. (2016) · Blood Reviews · doi:10.1016/j.blre.2016.10.002 · Cited by 156

Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis

Zhang, X., Chiang, H.-C., Wang, Y., Zhang, C., Smith, S. A., Zhao, X., Nair, S. J., Michalek, J. E., Jatoi, I., Lautner, M. A., et al. (2017) · Nature Communications · doi:10.1038/ncomms15908 · Cited by 155

BRCA2 suppresses replication stress-induced mitotic and G1 abnormalities through homologous recombination

Feng, W., & Jasin, M. (2017) · Nature Communications · doi:10.1038/s41467-017-00634-0 · Cited by 161

Advances in understanding DNA processing and protection at stalled replication forks

Rickman, K. A., & Smogorzewska, A. (2019) · The Journal of Cell Biology · doi:10.1083/jcb.201809012 · Cited by 160

Moonlighting at replication forks – a new life for homologous recombination proteins BRCA 1, BRCA 2 and RAD 51

Kolinjivadi, A. M., Sannino, V., Antoni, A. D., Técher, H., Baldi, G., & Costanzo, V. (2017) · FEBS Letters · doi:10.1002/1873-3468.12556 · Cited by 155

Trial Watch: Targeting ATM–CHK2 and ATR–CHK1 pathways for anticancer therapy

Manic, G., Obrist, F., Sistigu, A., & Vitale, I. (2015) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1012976 · Cited by 152

RAD-ical New Insights into RAD51 Regulation

Sullivan, M. R., & Bernstein, K. A. (2018) · Genes · doi:10.3390/genes9120629 · Cited by 152

A High-Throughput Functional Complementation Assay for Classification of BRCA1 Missense Variants

Bouwman, P., van der Gulden, H., van der Heijden, I., Drost, R., Klijn, C. N., Prasetyanti, P., Pieterse, M., Wientjens, E., Seibler, J., Hogervorst, F. B. L., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0094 · Cited by 140

Emerging functions of Fanconi anemia genes in replication fork protection pathways

Kolinjivadi, A. M., Crismani, W., & Ngeow, J. Y. Y. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa087 · Cited by 29

To the Rescue: The Fanconi Anemia Genome Stability Pathway Salvages Replication Forks

Moldovan, G., & D’Andrea, A. D. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.006 · Cited by 22

FANCD2, FANCJ and BRCA2 cooperate to promote replication fork recovery independently of the Fanconi Anemia core complex

Raghunandan, M., Chaudhury, I., Kelich, S. L., Hanenberg, H., & Sobeck, A. (2015) · Cell Cycle · doi:10.4161/15384101.2014.987614 · Cited by 74

Functional Interplay between BRCA2/FancD1 and FancC in DNA Repair

Kitao, H., Yamamoto, K., Matsushita, N., Ohzeki, M., Ishiai, M., & Takata, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603290200 · Cited by 42

Fanconi-Anemia-Associated Mutations Destabilize RAD51 Filaments and Impair Replication Fork Protection

Zadorozhny, K., Sannino, V., Beláň, O., Mlčoušková, J., Špı́rek, M., Costanzo, V., & Krejčí, L. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.062 · Cited by 64